Genesis Biosystems, Inc.
Genesis Biosystems, Inc., headquartered in the United States, is a leading innovator in the medical device industry, specialising in advanced solutions for the healthcare sector. Founded in 2006, the company has established itself as a key player in the development of cutting-edge technologies for tissue regeneration and wound care. With a focus on products such as the innovative Genesis® System, Genesis Biosystems offers unique, evidence-based solutions that enhance patient outcomes and streamline clinical workflows. The company’s commitment to quality and innovation has earned it a strong market position, recognised for its contributions to improving healthcare delivery. As it continues to expand its operational reach, Genesis Biosystems remains dedicated to advancing the field of regenerative medicine.
DitchCarbon Score
How does Genesis Biosystems, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Genesis Biosystems, Inc.'s score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Genesis Biosystems, Inc.'s reported carbon emissions
Genesis Biosystems, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Genesis Biosystems appears to lack formal commitments to carbon reduction initiatives or industry-standard climate frameworks such as the Science Based Targets initiative (SBTi). Without emissions data or reduction strategies, it is challenging to assess their environmental impact or commitment to sustainability within the biotechnology sector. In the context of the industry, many companies are increasingly adopting ambitious climate goals and transparency in emissions reporting. However, Genesis Biosystems has yet to establish a public stance or framework regarding its carbon footprint or climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Genesis Biosystems, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
